Could 'Good' bacteria beat a common vaginal infection?
NCT ID NCT07418996
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether vaginal capsules containing live lactobacilli (good bacteria) are safe and tolerable for treating bacterial vaginosis (BV), a common infection. Fifty-seven women with BV took either the lactobacillus capsules or the standard antibiotic metronidazole. The main goal was to check for side effects, with secondary goals looking at cure and recurrence rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- live lactobacillus vaginal capsules
- What this could lead to
- If successful, this could offer a new treatment option for bacterial vaginosis that uses beneficial bacteria instead of antibiotics.
- What could go wrong
- This is a small early-phase trial focused on safety, not effectiveness. The treatment may not work better than existing options, and results may not apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS (BV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guangdong Longchuangji Pharmaceutical Co., Ltd.
Chaozhou, Guangdong, 521000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.